Main content

Hormones: They Cost How Much?

Have pharmaceutical companies been hiking prices on life-saving drugs for pure profit? Justin Rowlatt looks at two hormonal drugs: Epipens in the US and Hydrocortisone in the UK.

Have pharmaceutical companies been hiking prices on life-saving drugs for pure profit? Justin Rowlatt looks at two hormonal drugs that have experienced eye-watering price increases.

In the US, epipens - which are used for example to save the lives of children experiencing violent allergic reactions - there has been a public backlash against manufacturer Mylan, as the Βι¶ΉΤΌΕΔ's Michelle Fleury reports.

Meanwhile, back in the UK, endocrinologist Maralyn Druce of Barts Hospital vents her fury over the 12,000% increase in the price of another drug, hydrocortisone. And investigative journalist Billy Kenber of The Times newspaper explains how he exposed the regulatory flaw that made it possible.

Producer: Laurence Knight

(Picture: Epipen injected in the upper thigh; Credit: smartstock/Getty Images)

Available now

18 minutes

Last on

Wed 19 Jul 2017 07:32GMT

Broadcast

  • Wed 19 Jul 2017 07:32GMT

Business Daily Podcast

Download every programme.

Podcast